3 ms·
GSK only registered for 60+ in their trial. Most likely because the clinical endpoints are more significant/easier to measure, and also because the safety trade
by icegreentea2 3y ago
GSK only registered for 60+ in their trial. Most likely because the clinical endpoints are more significant/easier to measure, and also because the safety trade-off is more weighted towards intervention.
- dgacmu 3y agoTo GP, I'm sorry your family isn't eligible yet. Pfizer has an in-progress vaccine for which they had good phase 3 results in both older adults and expectant mothers (looking at the outcomes for the infants once born). Their FDA application is in progress and miiiight be done by summer: https://www.health.com/rsv-vaccine-for-pregnant-moms-approval-7185422 https://www.health.com/rsv-vaccine-for-pregnant-moms-approva... Fingers crossed for y'all. It would be awesome to remove RSV from the things you have to worry about as a new parent. (We had a pretty nasty case with our first. Didn't end up in the hospital but it was really close.)